# A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

> **NCT00400023** · PHASE1 · COMPLETED · sponsor: **Taiho Oncology, Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Tumors

## Interventions

- **DRUG:** S-1
- **DRUG:** FT

## Key facts

- **NCT ID:** NCT00400023
- **Lead sponsor:** Taiho Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400023, "A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00400023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*